Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Q2 2025 Earnings Call Transcript August 4, 2025
Praxis Precision Medicines, Inc. beats earnings expectations. Reported EPS is $-3.31, expectations were $-3.4.
Operator: Good day, and welcome to the Praxis Precision Medicine’s RADIANT Top Line Results and Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this call may be recorded. I would now like to turn the call over to Dan Ferry of LifeSci Advisors....
